BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29744849)

  • 1. Using Molecular Tweezers to Remodel Abnormal Protein Self-Assembly and Inhibit the Toxicity of Amyloidogenic Proteins.
    Malik R; Di J; Nair G; Attar A; Taylor K; Teng E; Klärner FG; Schrader T; Bitan G
    Methods Mol Biol; 2018; 1777():369-386. PubMed ID: 29744849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disrupting self-assembly and toxicity of amyloidogenic protein oligomers by "molecular tweezers" - from the test tube to animal models.
    Attar A; Bitan G
    Curr Pharm Des; 2014; 20(15):2469-83. PubMed ID: 23859557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Tweezers: Supramolecular Hosts with Broad-Spectrum Biological Applications.
    Shahpasand-Kroner H; Siddique I; Malik R; Linares GR; Ivanova MI; Ichida J; Weil T; Münch J; Sanchez-Garcia E; Klärner FG; Schrader T; Bitan G
    Pharmacol Rev; 2023 Mar; 75(2):263-308. PubMed ID: 36549866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simulation Studies of Amyloidogenic Polypeptides and Their Aggregates.
    Ilie IM; Caflisch A
    Chem Rev; 2019 Jun; 119(12):6956-6993. PubMed ID: 30973229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATR-FTIR Analysis of Amyloid Proteins.
    Ruysschaert JM; Raussens V
    Methods Mol Biol; 2018; 1777():69-81. PubMed ID: 29744828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulating self-assembly of amyloidogenic proteins as a therapeutic approach for neurodegenerative diseases: strategies and mechanisms.
    Liu T; Bitan G
    ChemMedChem; 2012 Mar; 7(3):359-74. PubMed ID: 22323134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interrogating Amyloid Aggregates using Fluorescent Probes.
    Aliyan A; Cook NP; Martí AA
    Chem Rev; 2019 Dec; 119(23):11819-11856. PubMed ID: 31675223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational evolution of polymorphic amyloid assemblies.
    Liang C; Hsieh MC; Li NX; Lynn DG
    Curr Opin Struct Biol; 2018 Aug; 51():135-140. PubMed ID: 29729574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic diversity of amyloid oligomers.
    Dear AJ; Michaels TCT; Meisl G; Klenerman D; Wu S; Perrett S; Linse S; Dobson CM; Knowles TPJ
    Proc Natl Acad Sci U S A; 2020 Jun; 117(22):12087-12094. PubMed ID: 32414930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transthyretin suppresses the toxicity of oligomers formed by misfolded proteins in vitro.
    Cascella R; Conti S; Mannini B; Li X; Buxbaum JN; Tiribilli B; Chiti F; Cecchi C
    Biochim Biophys Acta; 2013 Dec; 1832(12):2302-14. PubMed ID: 24075940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational Evolution of Molecular Signatures during Amyloidogenic Protein Aggregation.
    Devitt G; Rice W; Crisford A; Nandhakumar I; Mudher A; Mahajan S
    ACS Chem Neurosci; 2019 Nov; 10(11):4593-4611. PubMed ID: 31661242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune Responses to Soluble Aggregates of Amyloidogenic Proteins Involved in Neurodegenerative Diseases: Overlapping Aggregation Prone and Autoimmunogenic regions.
    Kumar S; Thangakani AM; Nagarajan R; Singh SK; Velmurugan D; Gromiha MM
    Sci Rep; 2016 Feb; 6():22258. PubMed ID: 26924748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phthalocyanines as Molecular Scaffolds to Block Disease-Associated Protein Aggregation.
    Valiente-Gabioud AA; Miotto MC; Chesta ME; Lombardo V; Binolfi A; Fernández CO
    Acc Chem Res; 2016 May; 49(5):801-8. PubMed ID: 27136297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein folding, misfolding and aggregation: A tale of constructive to destructive assembly.
    Khan MV; Zakariya SM; Khan RH
    Int J Biol Macromol; 2018 Jun; 112():217-229. PubMed ID: 29374532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A covalent homodimer probing early oligomers along amyloid aggregation.
    Halabelian L; Relini A; Barbiroli A; Penco A; Bolognesi M; Ricagno S
    Sci Rep; 2015 Sep; 5():14651. PubMed ID: 26420657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibiting toxic aggregation of amyloidogenic proteins: a therapeutic strategy for protein misfolding diseases.
    Cheng B; Gong H; Xiao H; Petersen RB; Zheng L; Huang K
    Biochim Biophys Acta; 2013 Oct; 1830(10):4860-71. PubMed ID: 23820032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysine-specific molecular tweezers are broad-spectrum inhibitors of assembly and toxicity of amyloid proteins.
    Sinha S; Lopes DH; Du Z; Pang ES; Shanmugam A; Lomakin A; Talbiersky P; Tennstaedt A; McDaniel K; Bakshi R; Kuo PY; Ehrmann M; Benedek GB; Loo JA; Klärner FG; Schrader T; Wang C; Bitan G
    J Am Chem Soc; 2011 Oct; 133(42):16958-69. PubMed ID: 21916458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and pharmacological characterization of the molecular tweezer CLR01 - a broad-spectrum inhibitor of amyloid proteins' toxicity.
    Attar A; Chan WT; Klärner FG; Schrader T; Bitan G
    BMC Pharmacol Toxicol; 2014 Apr; 15():23. PubMed ID: 24735982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural, morphological, and functional diversity of amyloid oligomers.
    Breydo L; Uversky VN
    FEBS Lett; 2015 Sep; 589(19 Pt A):2640-8. PubMed ID: 26188543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aromatic interactions by molecular tweezers and clips in chemical and biological systems.
    Klärner FG; Schrader T
    Acc Chem Res; 2013 Apr; 46(4):967-78. PubMed ID: 22725723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.